Exton, Pennsylvania, Oct. 04, 2023 (GLOBE NEWSWIRE) Prior to the initial approval of Benlysta in 2011, systemic lupus erythematosus (SLE) patients and prescribers had limited options for the management
LONDON (dpa-AFX) - GSK plc (GSK, GSK.L) said that the US Food and Drug Administration has granted Orphan Drug Designation to Benlysta (belimumab), a B-cell inhibiting monoclonal antibody, for the
An analysis done by an advocacy group found that pharmaceutical companies have jacked up drug prices by over a thousand times in 2022 alone. Patients For Affordable Drugs (PFAD) penned the July [.]
LONDON (dpa-AFX) - GlaxoSmithKline Plc or GSK (GSK), said on Thursday that China's National Medical Products Administration or NMPA has approved Belimumab, sold under the brand name Benlysta, for